Amgen Soars: Q3 Profit Beats Forecasts, Key Weight-Loss Drug Data Set for Year-End Release
Amgen delivered strong financial results, beating Wall Street expectations for the third quarter. Product sales increased by 12% year-over-year. The biotech company’s revenue reached $9.56 billion. Adjusted earnings per share hit $5.64. Analysts had predicted lower figures for both. The company raised its full-year financial outlook. This optimism comes despite higher costs for developing its…